Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis

Published:2021-11-11 Issue: Volume: Page:
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Wang Changjun,Lin Yan,Zhu Hanjiang,Zhou Yidong,Mao Feng,Huang Xin,Zhou Xingtong,Cao Xi,Sun Qiang^ORCID

Funder

key projects in the national science and technology pillar program during the twelfth five‐year plan period

beijing municipal science and technology project

key laboratory of chemical biology and traditional chinese medicine research, ministry of education

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12282-021-01312-2.pdf

Reference36 articles.

1. Tung NM, Boughey JC, Pierce LJ, Robson ME, Bedrosian I, Dietz JR, et al. Management of hereditary breast cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline. J Clin Oncol. 2020;38(18):2080–106.

2. Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, et al. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. Lancet Oncol. 2018;19(2):169–80.

3. Zhao W, Wiese C, Kwon Y, Hromas R, Sung P. The BRCA tumor suppressor network in chromosome damage repair by homologous recombination. Annu Rev Biochem. 2019;20(88):221–45.

4. Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA. 2008;299(2):194–201.

5. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336(20):1401–8.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers;npj Breast Cancer;2024-07-26

2. Management and Clinical Outcomes of Breast Cancer in Women Diagnosed with Hereditary Cancer Syndromes in a Clinic-Based Sample from Colombia;Cancers;2024-05-26

3. Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?;JNCI: Journal of the National Cancer Institute;2023-08-21

4. Management of breast cancer patients with BRCA gene mutations in Jordan: perspectives and challenges;Hospital Practice;2023-08-08

5. An overview of the research progress of BRCA gene mutations in breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3